Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

...

Attendees

 Name

Organization

Hung Luu

Children’s

Riki Merrick

Vernetzt, APHL

Andrea Pitkus

UW

Pam Banning

3M - Solventum

Xavier Gansel

Biomerieux

Amy McCormick

Epic

Dan Rutz

Epic

Rob Rae

CAP

Rob Hausam

Hausam Consulting

Sandy Jones

CDC

Stan Huff

Graphite

Ed Heierman

Abbott / IICC

Andrew Quinn

 

Laurent Lardin

Biomerieux

Anthony Killeen

UMN

Craig Collom

 

Marti Velezis

 Sonrisa / FDA

Walter Sujansky

FDA

Susan Downer

JMC

Ralf Herzog

Roche

Cornelia Felder

Roche

Daniel Golson

JMC

Andrea Prada

JMC

Maria Sagat

 CAPCAP

Raja Cholan

FDA

Russ Ott

FDA

Akila Namasivayam

FDA

Desiree Mustaquim

CDC

Carmen Pugh

CDC

Christina Gallegos

APHL

John Spinosa

Lantana

Matthew Dietz

FDA

Agenda and Notes

Topic

Notes

Call Schedule

send OOO via chat or email

 LIDR White Paper Review

Reviewing the comments on the LIDR White Paper = LIDR White Paper

Discussion:

Added Title

replaced “class” of LOINCs with set of LOINCs

talked about the EBV study - cited was done on LDTs, while follow up done on FDA approved tests found less variations, decided to keep older reference in, but adjust sentence to include the newer study - talked about the fact that since we know of the vairation most organizations have policy to not merge results form different labs

Update figure 6 to differentiate between kind (LIDR) and instnadce data going from labs to all its users = add box for LIS/LIMS in Clinical Laboratory boc and make different style arrows out of that to EHR-s and make research and PH systems instead of organizations

add a bi-directional arrow between LDIR and Trusted Certification body to allow updates to LIDR based on lab LOINC coding observed during certification, that is deemed allowable - example would be timed tests that may not be in the manufacturer provided LIDR inputadjust several sentences so that the issue of proper use of LOINC model is highlighted and showing different LOINC mapping approaches (while also pointing people to the right things to do - like including SPM.

Update LOINCs in Figure 1 to use mass concentration and use HDL on Ser/Plas - Riki to do

Check with Walter on the references - Riki to do

Open To Dos:

  • Update reference style to use the numbers with reference Section (Riki has that prepped)

  • Reviewed comments on introduction - Still need to check for best place to talk about CLSI AUTO-16/IHE LAW (question: has anyone implemented in the US in production?)

  • Andrea to write up her sentences as per comments

GOAL: Get to Will forward to SC for their 12/3 call !!!so they can start reading - make sure they know it is still draft with a few tweaks needed

Review examples of merged cell LIVD file entries

https://aphlinformatics.atlassian.net/wiki/download/attachments/1938718763/Copy-HIV-Diagnostic-LOINC-Map_v5.xlsx?api=v2

essentially the repeating cells were merged for readability, they all would be separate LIVD file entries with the same UDI

Reviewing minutes from the last call - Action Item Follow up

Next call

Monday 12/09/2024 9:05 - 9:55 AM ET

Adjourned

9:?? 52 AM ET

Action items

  •  

Quick decisions not requiring context or tracking

...